Cander, SonerÇoban, SonerAltuner, ŞakirÖz Gül, ÖzenYetgin, Zeynel AbidinUçar, Hakan2024-02-192024-02-192014-08Cander, S. vd. (2014). "Prevalence and correlates of erectile dysfunction in type 2 diabetes mellitus: A cross-sectional single-center study among Turkish patients". Metabolic Syndrome and Related Disorders, 12(6), 324-329.1540-4196https://www.liebertpub.com/doi/10.1089/met.2013.0150https://hdl.handle.net/11452/39841Objective: The aim of this study was to evaluate prevalence of erectile dysfunction (ED) in patients with type 2 diabetes mellitus (T2DM) in relation to vascular and neurogenic correlates. Methods: A total of 116 males including T2DM patients [n = 68; mean age, 56.7 (5.8) years] and age-matched healthy controls [n = 48; mean age, 57.0 (6.6) years] were included in this cross-sectional single-center study. Data on anthropometrics, blood biochemistry, concomitant hypertension, hyperlipidemia, and coronary artery disease (CAD) were recorded in each subject along with measurement of carotid artery intima media thickness (CIMT) and evaluation of erectile dysfunction (ED) via International Index of Erectile Function (IIEF-5) Questionnaire. A univariate analysis was performed to determine the relationship of cardiovascular risk factors and diabetes-related complications to ED. Results: Patient and control groups were similar in terms of percentage patients with hyperlipidemia (51.5% and 39.6%, respectively) and CAD (33.8% and 22.9%, respectively), whereas concomitant hypertension was more common (P = 0.05) and CIMT values were significantly higher (P = 0.020) in patients with T2DM compared with controls. Polyneuropathy was noted in 46.2% of patients, nephropathy in 30.8%, and retinopathy in 33.8%. ED scores were significantly lower in patients than controls [14.3 (7.3) vs. 18.2 (6.3), P = 0.004] with a significantly higher percentage of patients than controls in the category of severe dysfunction (29.4 vs. 10.4%, P = 0.014). Univariate analysis revealed that diabetic polyneuropathy was the only factor to be associated with higher likelihood (93.3% in the presence and 60.0% in the absence of neuropathy) and severity (43.3% in the presence and 14.3% in the absence of neuropathy) of ED (P = 0.004). Conclusion: Findings from the present cross-sectional single-center study revealed the prevalence of ED to be considerably higher in patients with T2DM than age-matched healthy controls, with identification of diabetic polyneuropathy as the only risk factor associated with higher likelihood and more severe forms of ED.eninfo:eu-repo/semantics/closedAccessEndothelial dysfunctionImpotenceInternational indexAssociationSmooth-musclePathophysiologyMenRelaxationResearch & experimental medicineAgedCross-sectional studiesDiabetes complicationsDiabetes mellitus, type 2Erectile dysfunctionFemaleHeart function testsHumansMaleMiddle agedPrevalenceRisk factorsTurkeyArticle0003401965000042-s2.0-8490479329632432912624666397https://doi.org/10.1089/met.2013.0150Medicine, research & experimentalImpotence; Phosphodiesterase V Inhibitor; TadalafilAdultArticleCardiovascular riskControlled studyDiabetic nephropathyDiabetic neuropathyDiabetic patientDiabetic retinopathyDisease severityErectile dysfunctionHigh risk patientHumanHyperlipidemiaHypertensionInternational index of erectile functionMajor clinical studyMaleNon insulin dependent diabetes mellitusPrevalencePriority journalRisk factorTurk (people)AgedBloodComplicationCross-sectional studyDiabetes complicationsDiabetes mellitus, type 2Erectile dysfunctionFemaleHeart function testMiddle agedTurkey1557-8518